Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Derivo Embolization Device for the Treatment of Intracranial Aneurysms.

Trivelato FP, Abud DG, Ulhôa AC, Waihrich ES, Abud TG, Castro Afonso LH, Nakiri GS, de Castro GD, Parente BSM, Dos Santos Silva R, Manzato LB, Bonadio LE, Viana DC, Vanzin JR, Baccin CE, Rezende MTS.

Stroke. 2019 Jul 10:STROKEAHA119025407. doi: 10.1161/STROKEAHA.119.025407. [Epub ahead of print]

PMID:
31288675
2.

Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer.

Govindan R, Senan S, Dickgreber N, Provencio M, Wu YL, Syrigos K, Parente B, Wilson M, Ziemiecki R, Chouaki N, Hossain A, San Antonio B, Winfree K, Vokes EE.

Curr Med Res Opin. 2019 Jul 5:1-7. doi: 10.1080/03007995.2019.1623185. [Epub ahead of print]

PMID:
31125266
3.

Spinal Cord Stimulation for Restless Legs Syndrome: Case Series and Mechanistic Hypothesis.

Adil SM, Han JL, Parente BA, Hickey P, Lad SP.

Stereotact Funct Neurosurg. 2019;97(1):31-36. doi: 10.1159/000494737. Epub 2019 Apr 4.

PMID:
30947223
4.

Healthcare Economics of Hydrocephalus After Aneurysmal Subarachnoid Hemorrhage in the United States.

Adil SM, Liu B, Charalambous LT, Kiyani M, Gramer R, Swisher CB, Verbick LZ, McCabe A, Parente BA, Pagadala P, Lad SP.

Transl Stroke Res. 2019 Mar 13. doi: 10.1007/s12975-019-00697-9. [Epub ahead of print]

PMID:
30864050
5.

Prevalence and Cost Analysis of Chronic Pain After Hernia Repair: A Potential Alternative Approach With Neurostimulation.

Elsamadicy AA, Ashraf B, Ren X, Sergesketter AR, Charalambous L, Kemeny H, Ejikeme T, Yang S, Pagadala P, Parente B, Xie J, Pappas TN, Lad SP.

Neuromodulation. 2018 Oct 15. doi: 10.1111/ner.12871. [Epub ahead of print]

PMID:
30320933
6.

Down the Rabbit Hole: Specialty Influence on SCS Outcomes.

Lad SP, Yang S, Xie J, Farjat A, Pagadala P, Parente B.

Neuromodulation. 2018 Jun;21(4):417-420. doi: 10.1111/ner.12789. No abstract available.

PMID:
29975008
7.

Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.

Middleton G, Gridelli C, De Marinis F, Pujol JL, Reck M, Ramlau R, Parente B, Pieters T, Visseren-Grul CM, San Antonio B, John WJ, Zimmermann AH, Chouaki N, Paz-Ares L.

Curr Med Res Opin. 2018 May;34(5):865-871. doi: 10.1080/03007995.2018.1439462. Epub 2018 Mar 27.

PMID:
29424248
8.

Drivers and Risk Factors of Unplanned 30-Day Readmission Following Spinal Cord Stimulator Implantation.

Elsamadicy AA, Sergesketter A, Ren X, Mohammed Qasim Hussaini S, Laarakker A, Rahimpour S, Ejikeme T, Yang S, Pagadala P, Parente B, Xie J, Lad SP.

Neuromodulation. 2018 Jan;21(1):87-92. doi: 10.1111/ner.12689. Epub 2017 Sep 29.

9.

Prevalence and Cost Analysis of Complex Regional Pain Syndrome (CRPS): A Role for Neuromodulation.

Elsamadicy AA, Yang S, Sergesketter AR, Ashraf B, Charalambous L, Kemeny H, Ejikeme T, Ren X, Pagadala P, Parente B, Xie J, Lad SP.

Neuromodulation. 2018 Jul;21(5):423-430. doi: 10.1111/ner.12691. Epub 2017 Sep 29. Review.

10.

Increasing Rates of Imaging in Failed Back Surgery Syndrome Patients: Implications for Spinal Cord Stimulation.

Farber SH, Han JL, Petraglia Iii FW, Gramer R, Yang S, Pagadala P, Parente B, Xie J, Petrella JR, Lad SP.

Pain Physician. 2017 Sep;20(6):E969-E977.

11.

Long-term Cost Utility of Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome.

Farber SH, Han JL, Elsamadicy AA, Hussaini Q, Yang S, Pagadala P, Parente B, Xie J, Lad SP.

Pain Physician. 2017 Sep;20(6):E797-E805.

12.

Effect of statins on survival in patients undergoing dialysis access for end-stage renal disease.

De Rango P, Parente B, Farchioni L, Cieri E, Fiorucci B, Pelliccia S, Manzone A, Simonte G, Lenti M.

Semin Vasc Surg. 2016 Dec;29(4):198-205. doi: 10.1053/j.semvascsurg.2017.03.001. Epub 2017 Mar 22.

PMID:
28779787
13.

Rheolytic Thrombectomy with AngioJet® Is Safe and Effective in Revascularization of Renal Arteries' Acute Occlusion on Previous Complex Aortic Endovascular Repair.

Fiorucci B, Isernia G, Simonte G, Farchioni L, Parente B, Parlani G, Lenti M.

Ann Vasc Surg. 2017 Nov;45:270.e1-270.e6. doi: 10.1016/j.avsg.2017.07.015. Epub 2017 Jul 21.

PMID:
28739460
14.

Ultrasonography for endoleak detection after endoluminal abdominal aortic aneurysm repair.

Abraha I, Luchetta ML, De Florio R, Cozzolino F, Casazza G, Duca P, Parente B, Orso M, Germani A, Eusebi P, Montedori A.

Cochrane Database Syst Rev. 2017 Jun 9;6:CD010296. doi: 10.1002/14651858.CD010296.pub2. Review.

15.

Specialty-Based Variations in Spinal Cord Stimulation Success Rates for Treatment of Chronic Pain.

Hussaini SMQ, Murphy KR, Han JL, Elsamadicy AA, Yang S, Premji A, Parente B, Xie J, Pagadala P, Lad SP.

Neuromodulation. 2017 Jun;20(4):340-347. doi: 10.1111/ner.12582. Epub 2017 Apr 2.

16.

Impact of Insurance Provider on Overall Costs in Failed Back Surgery Syndrome: A Cost Study of 122,827 Patients.

Elsamadicy AA, Farber SH, Yang S, Hussaini SMQ, Murphy KR, Sergesketter A, Suryadevara CM, Pagadala P, Parente B, Xie J, Lad SP.

Neuromodulation. 2017 Jun;20(4):354-360. doi: 10.1111/ner.12584. Epub 2017 Mar 21.

17.

Explantation Rates and Healthcare Resource Utilization in Spinal Cord Stimulation.

Han JL, Murphy KR, Hussaini SMQ, Yang S, Parente B, Xie J, Pagadala P, Lad SP.

Neuromodulation. 2017 Jun;20(4):331-339. doi: 10.1111/ner.12567. Epub 2017 Feb 15.

18.

Prevalence of Specific Types of Pain Diagnoses in a Sample of United States Adults.

Murphy KR, Han JL, Yang S, Hussaini SM, Elsamadicy AA, Parente B, Xie J, Pagadala P, Lad SP.

Pain Physician. 2017 Feb;20(2):E257-E268.

19.

The Volume-Outcome Effect: Impact on Trial-to-Permanent Conversion Rates in Spinal Cord Stimulation.

Murphy KR, Han JL, Hussaini SM, Yang S, Parente B, Xie J, Lad SP.

Neuromodulation. 2017 Apr;20(3):256-262. doi: 10.1111/ner.12526. Epub 2016 Oct 3.

21.

Osteochondromas: An Unusual Cause of Vascular Disease in Young Patients: 2 Clinical Cases.

Parente B, Fiorucci B, Simonte G, Brambilla DM, Lenti M.

Ann Vasc Surg. 2016 Apr;32:129.e7-11. doi: 10.1016/j.avsg.2015.09.029. Epub 2016 Jan 22.

PMID:
26806252
22.

The Incidence of Spinal Cord Injury in Implantation of Percutaneous and Paddle Electrodes for Spinal Cord Stimulation.

Petraglia FW 3rd, Farber SH, Gramer R, Verla T, Wang F, Thomas S, Parente B, Lad SP.

Neuromodulation. 2016 Jan;19(1):85-90. doi: 10.1111/ner.12370. Epub 2015 Dec 8.

23.

Comparison of Bilateral vs. Staged Unilateral Deep Brain Stimulation (DBS) in Parkinson's Disease in Patients Under 70 Years of Age.

Petraglia FW 3rd, Farber SH, Han JL, Verla T, Gallis J, Lokhnygina Y, Parente B, Hickey P, Turner DA, Lad SP.

Neuromodulation. 2016 Jan;19(1):31-7. doi: 10.1111/ner.12351. Epub 2015 Nov 16.

24.

Sarcoma of the Thigh: Radical Excision with Arterial Reconstruction Using the Contralateral Saphenous Vein.

Covarelli P, Boselli C, Burini G, Parente B, Loschi D, Lenti M, Rulli A.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S334. doi: 10.1245/s10434-015-4844-1. Epub 2015 Sep 8. No abstract available.

PMID:
26350362
25.

The Value of Indirect Teaching Strategies in Enhancing Student-Coaches' Learning Engagement.

Mesquita I, Coutinho P, De Martin-Silva L, Parente B, Faria M, Afonso J.

J Sports Sci Med. 2015 Aug 11;14(3):657-68. eCollection 2015 Sep.

26.

Diffuse vascular hamartoma with malignant behavior.

Ladeira I, Neves S, Almeida J, Parente B, Couceiro A, Moura Sá J.

Respir Med Case Rep. 2015 May 22;15:125-7. doi: 10.1016/j.rmcr.2015.05.007. eCollection 2015.

27.

Postmortem diffusion MRI of the human brainstem and thalamus for deep brain stimulator electrode localization.

Calabrese E, Hickey P, Hulette C, Zhang J, Parente B, Lad SP, Johnson GA.

Hum Brain Mapp. 2015 Aug;36(8):3167-78. doi: 10.1002/hbm.22836. Epub 2015 Jun 3.

28.

Impact of advancing age on post-operative complications of deep brain stimulation surgery for essential tremor.

Verla T, Marky A, Farber H, Petraglia FW 3rd, Gallis J, Lokhnygina Y, Parente B, Hickey P, Turner DA, Lad SP.

J Clin Neurosci. 2015 May;22(5):872-6. doi: 10.1016/j.jocn.2014.11.005. Epub 2015 Feb 7.

29.

Cost and Burden of Non-Small Cell Lung Cancer's in Portugal.

Borges M, Gouveia M, Alarcão J, Sousa R, Teixeira E, Barata F, Laranjeira E, Lopes F, Parente B, Pinheiro L, Vaz-Carneiro A, Costa J.

Value Health. 2014 Nov;17(7):A626. doi: 10.1016/j.jval.2014.08.2228. Epub 2014 Oct 26. No abstract available.

30.

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data.

Rossi A, Chiodini P, Sun JM, O'Brien ME, von Plessen C, Barata F, Park K, Popat S, Bergman B, Parente B, Gallo C, Gridelli C, Perrone F, Di Maio M.

Lancet Oncol. 2014 Oct;15(11):1254-62. doi: 10.1016/S1470-2045(14)70402-4. Epub 2014 Sep 14. Review.

PMID:
25232001
31.

Effect of advancing age on outcomes of deep brain stimulation for Parkinson disease.

DeLong MR, Huang KT, Gallis J, Lokhnygina Y, Parente B, Hickey P, Turner DA, Lad SP.

JAMA Neurol. 2014 Oct;71(10):1290-5. doi: 10.1001/jamaneurol.2014.1272.

PMID:
25155481
32.

Nutritional screening of pulmonology department inpatients.

Maia I, Xará S, Dias I, Parente B, Amaral TF.

Rev Port Pneumol. 2014 Nov-Dec;20(6):293-8. doi: 10.1016/j.rppneu.2014.01.004. Epub 2014 Mar 20.

33.

Lung cancer in Northern Portugal: A hospital-based study.

Hespanhol V, Parente B, Araújo A, Cunha J, Fernandes A, Figueiredo MM, Neveda R, Soares M, João F, Queiroga H.

Rev Port Pneumol. 2013 Nov-Dec;19(6):245-51. doi: 10.1016/j.rppneu.2013.05.005. Epub 2013 Oct 9. English, Portuguese.

34.

Total endovascular solution for complex visceral aneurysms.

Verzini F, Biello A, Marucchini A, Parente B, Parlani G, Cao P.

J Vasc Surg. 2013 Nov;58(5):1412-6. doi: 10.1016/j.jvs.2013.05.045. Epub 2013 Jul 1.

35.

Dermatomyositis as the first manifestation of a lung tumor.

Castro AS, Barroso A, Parente B.

Rev Port Pneumol. 2013 Jul-Aug;19(4):179-83. doi: 10.1016/j.rppneu.2012.11.002. Epub 2013 Apr 17. English, Portuguese.

36.

Well-differentiated papillary mesothelioma: clustering in a Portuguese family with a germline BAP1 mutation.

Ribeiro C, Campelos S, Moura CS, Machado JC, Justino A, Parente B.

Ann Oncol. 2013 Aug;24(8):2147-50. doi: 10.1093/annonc/mdt135. Epub 2013 Apr 12.

PMID:
23585512
37.

Dyspnea and wheezing: still a challenge for pulmonologists.

Castro AS, Barroso A, Conde S, Parente B.

Case Rep Pulmonol. 2012;2012:610949. doi: 10.1155/2012/610949. Epub 2012 Dec 22.

38.

Advanced lung adenocarcinoma in an EGFR-positive patient treated with Erlotinib for 52 months.

Gonçalves I, Ladeira I, Castro A, Antunes A, Barroso A, Parente B.

Respir Med Case Rep. 2013 Jul 17;10:10-2. doi: 10.1016/j.rmcr.2013.06.003. eCollection 2013.

39.

Epidermal growth factor receptor mutation study for 5 years, in a population of patients with non-small cell lung cancer.

Castro AS, Parente B, Gonçalves I, Antunes A, Barroso A, Conde S, Neves S, Machado JC.

Rev Port Pneumol. 2013 Jan-Feb;19(1):7-12. doi: 10.1016/j.rppneu.2012.08.002. Epub 2012 Dec 21. English, Portuguese.

40.

Tracheal bronchus with metachronous tumor.

Monteiro R, Gonçalves I, Parente B, Moura e Sá J.

J Bronchology Interv Pulmonol. 2012 Oct;19(4):343-4. doi: 10.1097/LBR.0b013e31826c64d4.

PMID:
23207541
41.

Safety, resource use, and quality of life in paramount: a phase III study of maintenance pemetrexed versus placebo after induction pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.

Gridelli C, de Marinis F, Pujol JL, Reck M, Ramlau R, Parente B, Pieters T, Middleton G, Corral J, Winfree K, Melemed S, Zimmermann A, John W, Beyrer J, Chouaki N, Visseren-Grul C, Paz-Ares LG.

J Thorac Oncol. 2012 Nov;7(11):1713-21. doi: 10.1097/JTO.0b013e318267cf84.

42.

Personalizing medicine: strategies for implementing the evaluation of anaplastic lymphoma kinase rearrangement in non-small-cell lung cancer in Portugal.

Araújo A, Coelho A, de Mello RA, Azevedo I, Soares M, Queiroga H, Teixeira E, Parente B, Barata F.

Rev Port Pneumol. 2012 Sep-Oct;18(5):244-6. doi: 10.1016/j.rppneu.2012.04.011. Epub 2012 Jun 29. English, Portuguese. No abstract available.

43.

Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study.

Vergnenegre A, Smit EF, Toy E, Parente B, Schmitz S, Kraaij K, Soldatenkova V, Visseren-Grul C, Zanotti G, Taipale K, Moro-Sibilot D.

Curr Med Res Opin. 2012 Aug;28(8):1253-62. doi: 10.1185/03007995.2012.703133. Epub 2012 Jul 5.

PMID:
22697276
44.

Bevacizumab for the treatment of nonsquamous non-small-cell lung cancer in Portugal: a retrospective, multicenter study.

Estevinho F, Soares M, Azevedo I, Queiroga H, Parente B, Brito U, Teixeira E, Sotto-Mayor R, Araújo A.

Cancer Manag Res. 2012;4:91-7. doi: 10.2147/CMAR.S29672. Epub 2012 Mar 13.

45.

Percutaneous approach in the maintenance and salvage of dysfunctional autologous vascular access for dialysis.

De Rango P, Parente B, Cieri E, Bonanno P, Farchioni L, Manzone A, Verzini F.

J Vasc Access. 2012 Jul-Sep;13(3):381-7. doi: 10.5301/jva.5000060.

PMID:
22367648
46.

Treatment of ruptured intra-cranial internal carotid artery dissection using a flow-diverter stent.

Nakiri GS, Al-Khawaldeh M, Parente B, Kessler I, Gory B, Riva R, Mounayer C.

J Neuroradiol. 2012 Oct;39(4):271-5. doi: 10.1016/j.neurad.2011.10.005. Epub 2012 Jan 9.

PMID:
22226815
47.

[Undernutrition and quality of life in non small cell lung cancer patients].

Xará S, Amaral TF, Parente B.

Rev Port Pneumol. 2011 Jul-Aug;17(4):153-8. doi: 10.1016/j.rppneu.2011.01.006. Epub 2011 Jun 12. Portuguese.

48.

Portuguese Journal of Pulmonology: year-in-review 2009.

Drummond M, Cordeiro CR, Hespanhol V, Gomes MJ, de Almeida AB, Parente B, Pinto P.

Rev Port Pneumol. 2010 Nov-Dec;16(6):899-906. English, Portuguese.

49.

Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study.

Moro-Sibilot D, Vergnenegre A, Smit EF, Toy E, Parente B, Schmitz S, Kraaij K, Visseren-Grul C, Soldatenkova V, Arellano J, Leteneux C.

Curr Med Res Opin. 2010 Nov;26(11):2661-72. doi: 10.1185/03007995.2010.525489. Epub 2010 Oct 14.

PMID:
20942749
50.

Description and management of cutaneous side effects during erlotinib and cetuximab treatment in lung and colorectal cancer patients: a prospective and descriptive study of 19 patients.

de Noronha e Menezes NM, Lima R, Moreira A, Varela P, Barroso A, Baptista A, Parente B.

Eur J Dermatol. 2009 May-Jun;19(3):248-51. doi: 10.1684/ejd.2009.0650. Epub 2009 Mar 3.

PMID:
19258241

Supplemental Content

Loading ...
Support Center